Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082117 | SCV000114063 | uncertain significance | not provided | 2012-12-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313819 | SCV000847958 | likely benign | Inborn genetic diseases | 2016-10-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV003231131 | SCV001001872 | benign | Sotos syndrome | 2022-10-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000082117 | SCV001942666 | benign | not provided | 2021-03-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003231131 | SCV002055001 | likely benign | Sotos syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000082117 | SCV005075716 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | NSD1: BP4, BP7, BS1 |
Prevention |
RCV003945026 | SCV004763203 | likely benign | NSD1-related disorder | 2023-09-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |